Alerts will be sent to your verified email
Verify Email
UNJHAFOR
|
Unjha Formulations
|
iStreet Network
|
Beryl Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.14 % | 5.65 % | 2.54 % |
|
5yr average Equity Multiplier
|
1.74 | -0.18 | 2.23 |
|
5yr Average Asset Turnover Ratio
|
3.48 | 0.04 | 1.08 |
|
5yr Avg Net Profit Margin
|
1.88 % | 0.63 % | 0.66 % |
|
Price to Book
|
3.31 | 0.0 | 1.34 |
|
P/E
|
17.49 | 0.0 | 149.36 |
|
5yr Avg Cash Conversion Cycle
|
14.25 Days | 0.0 | -619.24 Days |
|
Inventory Days
|
26.1 Days | 0.0 | 36.1 Days |
|
Days Receivable
|
26.23 Days | 0.0 | 98.89 Days |
|
Days Payable
|
63.08 Days | 1316.12 Days | 969.29 Days |
|
5yr Average Interest Coverage Ratio
|
5.17 | -130.8 | 1.68 |
|
5yr Avg ROCE
|
20.73 % | -95.99 % | 5.73 % |
|
5yr Avg Operating Profit Margin
|
2.93 % | 0.8 % | 7.19 % |
|
5 yr average Debt to Equity
|
0.0 | -1.0 | 0.64 |
|
5yr CAGR Net Profit
|
-2.02 % | 45.41 % | 72.78 % |
|
5yr Average Return on Assets
|
6.49 % | -124.86 % | 1.31 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
36.92 % | 46.2 % | 26.38 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 1.46 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Unjha Formulations
|
iStreet Network
|
Beryl Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|